S E M Vonk, PharmD1, S W J Terheggen-Lagro, MD, PhD2, E G Haarman, MD, PhD2, H M Janssens, MD, PhD3, A H Maitland – van der Zee, PharmD, PhD3, E M Kemper, PharmD, PhD1,4, R A A Mathôt, PharmD, PhD1on behalf of the Amsterdam Mucociliary Clearance Disease (AMCD) research group
  1. Amsterdam UMC location University of Amsterdam, Department of Hospital Pharmacy & Clinical Pharmacology, Meibergdreef 9, Amsterdam, The Netherlands
  2. Amsterdam UMC location University of Amsterdam, Emma Children’s Hospital, Department of Pediatric Pulmonology and Allergy, Meibergdreef 9, Amsterdam, The Netherlands
  3. Department of Pediatrics, Division of Respiratory Medicine and Allergology, Erasmus MC-Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
  4. Amsterdam UMC location University of Amsterdam, Department of Pulmonary Medicine, Meibergdreef 9, Amsterdam, The Netherlands
  5. Amsterdam UMC location University of Amsterdam, Department of Vascular Medicine, Amsterdam, The Netherlands
Corresponding author:
S.E.M. Vonk, PharmD
Amsterdam UMC, location University of Amsterdam
Department of Hospital Pharmacy & Clinical Pharmacology
Meibergdreef 9
1105 AZ Amsterdam
Telephone: +31 (0)20 5669111
Email: s.e.vonk@amsterdamumc.nl